UPDATE : Tuesday, October 15, 2019
FDA OKs Gemvax & Kael's Alzheimer treatment for P2 trials
Gemvax & Kael has obtained U.S. Food and Drug Administration's investig...
by Lee Han-soo  |  2019-05-07 16:09
[Exclusive] MSD workers appalled by executive’s remarks on childcare leave
MSD Korea recently revised a policy to allow employees on child care leave ...
by Jeong Sae-im  |  2019-05-07 12:08
Dong-A ST posts robust Q1 profit
Dong-A ST said Friday that it recorded sales of 142.6 billion won ($121.8 m...
by Lee Han-soo  |  2019-05-03 16:49
Leading hepatitis C drug wins FDA nod for adolescents
AbbVie’s hepatitis C treatment Mavyret (glecaprevir/pibrentasvir), which wo...
by Kim Yun-mi  |  2019-05-03 15:51
GC surpasses 200-million mark in flu vaccine production
GC has become the first local company to manufacture more than 200 million ...
by Lee Han-soo  |  2019-05-03 14:39
Hanmi's short bowel syndrome treatment becomes orphan drug in US
The U.S. Food and Drug Administration has granted an orphan drug designatio...
by Lee Han-soo  |  2019-05-03 11:42
Ministry OKs Lilly Korea’s metastatic breast cancer treatment
Lilly Korea has received sales approval from the Ministry of Food and Drug ...
by Lee Han-soo  |  2019-05-02 18:11
GC marks sluggish sales in Q1
GC said Tuesday that sales by the company and its subsidiaries in the first...
by Lee Han-soo  |  2019-05-02 14:30
Daewoong logs ₩238.1 billion sales in Q1
Daewoong Pharmaceutical recorded 238.1 billion won ($247.8 million) in sale...
by Lee Han-soo  |  2019-05-02 14:09
‘MSD Korea’s monitoring program might be privacy breach’
MSD Korea’s “Self-Assurance” program, recording conversations of doctors at...
by Kim Yun-mi  |  2019-05-02 11:00
Hanmi posts ₩274 billion in Q1 sales
Hanmi Pharmaceutical said Tuesday that it recorded sales of 274.6 billion w...
by Lee Han-soo  |  2019-05-02 10:59
HanAll unveils P2 trial results at ARVO 2019
HanAll Biopharma has presented the phase 2 clinical trial for HL036, a dry ...
by Lee Han-soo  |  2019-04-30 16:31
Drugmakers brace for vaccine shortage amid surging hepatitis A cases
Pharmaceutical companies are closely monitoring the supply of hepatitis A v...
by Kim Yun-mi  |  2019-04-30 13:13
Daewoong gets positive reviews of its BTX in EU
Daewoong Pharmaceutical said Friday that the European Medicines Agency'...
by Lee Han-soo  |  2019-04-29 16:13
Yuyu releases research results for dry eye treatment in Canada
Yuyu Pharmaceutical has presented the results of a study for YDE, its pepti...
by Lee Han-soo  |  2019-04-29 14:33
Corestem fails to get insurance benefit for Lou Gehrig’s drug
A state-run health insurance review agency has refused to grant insurance b...
by Song Soo-youn  |  2019-04-26 15:43
Genexine, NeoImmuneTech apply combo treatment to breast cancer
Genexine, NeoImmuneTech have started administering its combination treatmen...
by Lee Han-soo  |  2019-04-26 12:00
GC wins $35.7 million flu vaccine contract from Latin America
GC said Thursday it has secured a $35.7 million contract to supply influenz...
by Lee Han-soo  |  2019-04-25 17:52
Hugel submits new drug application for BTX in China
Hugel has filed a new drug application (NDA) for Botulax, its botulinum tox...
by Lee Han-soo  |  2019-04-25 16:47
FDA OKs AbbVie’s plaque psoriasis treatment
The U.S. Food and Drug Administration approved Skyrizi (Ingredient: risanki...
by Lee Han-soo  |  2019-04-25 15:53
Back to Top